(Q83033686)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19096746%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

To stop or not to stop, that is the question (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19096746%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19096746%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

1 February 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19096746%20AND%20SRC:MED&resulttype=core&format=json

Osteoporosis International

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19096746%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19096746%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19096746%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

187-195

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19096746%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00198-008-0813-x

18 January 2020

exact match

0 references

cites work

Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin

1 reference

12 December 2020

The components of excess mortality after hip fracture

1 reference

12 December 2020

Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs

1 reference

12 December 2020

Fracture outcomes related to persistence and compliance with oral bisphosphonates

1 reference

12 December 2020

Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis

1 reference

12 December 2020

Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy?

1 reference

12 December 2020

Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib.

1 reference

12 December 2020

Recovery of trabecular and cortical bone turnover after discontinuation of risedronate and alendronate therapy in ovariectomized rats

1 reference

12 December 2020

Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial

1 reference

12 December 2020

Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial

1 reference

12 December 2020

Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy

1 reference

12 December 2020

Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD.

1 reference

12 December 2020

Mean wall thickness of trabecular bone packets in the human iliac crest: changes with age

1 reference

12 December 2020

Effect of calcium supplementation on hip fractures

1 reference

12 December 2020

Aging of microstructural compartments in human compact bone

1 reference

12 December 2020

Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial

1 reference

12 December 2020

Non-compliance: the Achilles' heel of anti-fracture efficacy

1 reference

12 December 2020

Risk of hip fracture after bisphosphonate discontinuation: implications for a drug holiday

1 reference

12 December 2020

Randomized Controlled Trial of Calcium in Healthy Older Women

1 reference

12 December 2020

A biomechanical analysis of the effects of resorption cavities on cancellous bone strength

1 reference

12 December 2020

Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution

1 reference

12 December 2020

Calcium plus vitamin D supplementation and the risk of fractures

1 reference

12 December 2020

Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized double-blind study

1 reference

12 December 2020

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.

1 reference

12 December 2020

Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis

1 reference

12 December 2020

Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women.

1 reference

12 December 2020

Intravenous zoledronic acid in postmenopausal women with low bone mineral density

1 reference

12 December 2020

Raloxifene enhances vertebral mechanical properties independent of bone density.

1 reference

12 December 2020

Fracture risk remains reduced one year after discontinuation of risedronate

1 reference

12 December 2020

Seven years of treatment with risedronate in women with postmenopausal osteoporosis

1 reference

12 December 2020

Treatment of postmenopausal osteoporosis

1 reference

12 December 2020

Bisphosphonate-induced osteopetrosis: novel bone modeling defects, metaphyseal osteopenia, and osteosclerosis fractures after drug exposure ceases

1 reference

12 December 2020

Risk of fracture among women who lose bone density during treatment with alendronate. The Fracture Intervention Trial

1 reference

12 December 2020

The effects of gonadotrophin-releasing hormone agonists on iliac crest cancellous bone structure in women with endometriosis

1 reference

12 December 2020

Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite

1 reference

12 December 2020

Relationship between duration of teriparatide therapy and clinical outcomes in postmenopausal women with osteoporosis

1 reference

12 December 2020

Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group

1 reference

12 December 2020

Severely suppressed bone turnover: a potential complication of alendronate therapy

1 reference

12 December 2020

Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate.

1 reference

12 December 2020

Efficacy of risedronate on clinical vertebral fractures within six months.

1 reference

12 December 2020

Changes in bone remodeling rate influence the degree of mineralization of bone

1 reference

12 December 2020

Hormone replacement therapy prevents osteoclastic hyperactivity: A histomorphometric study in early postmenopausal women

1 reference

12 December 2020

Bisphosphonate-induced osteopetrosis

1 reference

12 December 2020

Ten years' experience with alendronate for osteoporosis in postmenopausal women

1 reference

12 December 2020

Bone quality--the material and structural basis of bone strength and fragility

1 reference

12 December 2020

Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial

1 reference

12 December 2020

Effects of intravenous zoledronate on bone turnover and BMD persist for at least 24 months

1 reference

12 December 2020

Sustained nonvertebral fragility fracture risk reduction after discontinuation of teriparatide treatment

1 reference

12 December 2020

Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies

1 reference

12 December 2020

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial

1 reference

12 December 2020

Osteonecrosis of the jaw--do bisphosphonates pose a risk?

1 reference

12 December 2020

Bone fragility: failure of periosteal apposition to compensate for increased endocortical resorption in postmenopausal women

1 reference

12 December 2020

10.1007/S00198-008-0813-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19096746%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference